Pulmonary microvascular lesions regress in reperfused chronic thromboembolic pulmonary hypertension.
暂无分享,去创建一个
M. Humbert | E. Fadel | S. Eddahibi | F. Perros | P. Dorfmuller | O. Mercier | D. Boulate | J. Guihaire | P. Dartevelle | B. Decante | J. Arthur‐Ataam | L. Lamrani
[1] M. Humbert,et al. Microvascular disease in chronic thromboembolic pulmonary hypertension: a role for pulmonary veins and systemic vasculature , 2014, European Respiratory Journal.
[2] Nicholas W Morrell,et al. Relevant issues in the pathology and pathobiology of pulmonary hypertension. , 2013, Journal of the American College of Cardiology.
[3] E. Fadel,et al. Piglet Model of Chronic Pulmonary Hypertension , 2013, Pulmonary circulation.
[4] E. Fadel,et al. Chronic thromboembolic pulmonary hypertension: animal models , 2013, European Respiratory Journal.
[5] Robin Shandas,et al. High pulsatility flow stimulates smooth muscle cell hypertrophy and contractile protein expression. , 2013, American journal of physiology. Lung cellular and molecular physiology.
[6] M. Yeager,et al. Endothelin-1, the unfolded protein response, and persistent inflammation: role of pulmonary artery smooth muscle cells. , 2012, American journal of respiratory cell and molecular biology.
[7] E. Fadel,et al. Right lung ischemia induces contralateral pulmonary vasculopathy in an animal model. , 2012, The Journal of thoracic and cardiovascular surgery.
[8] F. Clubb,et al. Swine as Models in Biomedical Research and Toxicology Testing , 2012, Veterinary pathology.
[9] P. Dartevelle,et al. Surgical treatment of chronic thromboembolic pulmonary hypertension. , 2000, Canadian respiratory journal.
[10] J. Barberà,et al. Chronic Thromboembolic Pulmonary Hypertension (CTEPH): Results From an International Prospective Registry , 2011, Circulation.
[11] W. Klepetko,et al. Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. , 2011, The Journal of thoracic and cardiovascular surgery.
[12] T. Satoh,et al. Interleukin-6 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension , 2010, International journal of rheumatology.
[13] I. Lang. Advances in understanding the pathogenesis of chronic thromboembolic pulmonary hypertension , 2010, British journal of haematology.
[14] B. Housset,et al. Role for interleukin-6 in COPD-related pulmonary hypertension. , 2009, Chest.
[15] Robin Shandas,et al. Effects of Pathological Flow on Pulmonary Artery Endothelial Production of Vasoactive Mediators and Growth Factors , 2009, Journal of Vascular Research.
[16] E. Fadel,et al. Regression of flow-induced pulmonary arterial vasculopathy after flow correction in piglets. , 2009, The Journal of thoracic and cardiovascular surgery.
[17] T. Nawrot,et al. C-reactive protein: a new predictor of adverse outcome in pulmonary arterial hypertension. , 2009, Journal of the American College of Cardiology.
[18] B. Andersson,et al. Growth factors and interleukin-6 across the lung circulation in pulmonary hypertension , 2009, European Respiratory Journal.
[19] E. Mark,et al. Interleukin-6 Overexpression Induces Pulmonary Hypertension , 2009, Circulation research.
[20] S. Eddahibi,et al. Impact of interleukin-6 on hypoxia-induced pulmonary hypertension and lung inflammation in mice , 2009, Respiratory research.
[21] M. Humbert,et al. Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension. , 2008, American journal of respiratory and critical care medicine.
[22] John Jenkins,et al. Inflammation and ischemia-induced lung angiogenesis. , 2008, American journal of physiology. Lung cellular and molecular physiology.
[23] R. Lutter,et al. Hemodynamic and clinical correlates of endothelin-1 in chronic thromboembolic pulmonary hypertension. , 2006, Circulation journal : official journal of the Japanese Circulation Society.
[24] T. Kishimoto,et al. Interleukin-6 : discovery of a pleiotropic cytokine , 2022 .
[25] E. Fadel,et al. Regression of the systemic vasculature to the lung after removal of pulmonary artery obstruction. , 2006, American journal of respiratory and critical care medicine.
[26] H. Schäfers,et al. Circulating big endothelin-1: an active role in pulmonary thromboendarterectomy? , 2005, The Journal of thoracic and cardiovascular surgery.
[27] I. Salmon,et al. Signaling Molecules in Overcirculation-Induced Pulmonary Hypertension in Piglets: Effects of Sildenafil Therapy , 2004, Circulation.
[28] Gérald Simonneau,et al. Chronic thromboembolic pulmonary hypertension , 2004, European Respiratory Journal.
[29] E. Fadel,et al. Regression of postobstructive vasculopathy after revascularization of chronically obstructed pulmonary artery. , 2004, The Journal of thoracic and cardiovascular surgery.
[30] H. Morita,et al. Epoprostenol therapy decreases elevated circulating levels of monocyte chemoattractant protein-1 in patients with primary pulmonary hypertension. , 2004 .
[31] A. Branzi,et al. The endothelin system in pulmonary arterial hypertension. , 2004, Cardiovascular research.
[32] Ori Ben-Yehuda,et al. Preoperative Partitioning of Pulmonary Vascular Resistance Correlates With Early Outcome After Thromboendarterectomy for Chronic Thromboembolic Pulmonary Hypertension , 2004, Circulation.
[33] M. Humbert,et al. SERIES "ADVANCES IN PATHOBIOLOGY, DIAGNOSIS, AND TREATMENT OF PULMONARY HYPERTENSION" Edited by A.T. Dinh-Xuan, M. Humbert, R. Naeije Number 10 in this Series Chronic thromboembolic pulmonary hypertension , 2004 .
[34] P. Thistlethwaite,et al. Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. , 2003, The Annals of thoracic surgery.
[35] W. Mitzner,et al. Identification of genes promoting angiogenesis in mouse lung by transcriptional profiling. , 2003, American journal of respiratory cell and molecular biology.
[36] C. Pedersen,et al. Pulmonary vascular remodeling distal to pulmonary artery ligation is accompanied by upregulation of endothelin receptors and nitric oxide synthase. , 2000, Experimental lung research.
[37] R. Michel,et al. Endothelin reactivity and receptor profile of pulmonary vessels in postobstructive pulmonary vasculopathy. , 1997, American journal of physiology. Heart and circulatory physiology.
[38] N. Charan,et al. Angiogenesis in bronchial circulatory system after unilateral pulmonary artery obstruction. , 1997, Journal of applied physiology.
[39] M. Humbert,et al. Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. , 1995, American journal of respiratory and critical care medicine.
[40] D. Stewart,et al. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. , 1993, The New England journal of medicine.
[41] R. Michel,et al. Increased resistance in postobstructive pulmonary vasculopathy: structure-function relationships. , 1991, Journal of applied physiology.
[42] J. Edwards,et al. The Pathology of Hypertensive Pulmonary Vascular Disease: A Description of Six Grades of Structural Changes in the Pulmonary Arteries with Special Reference to Congenital Cardiac Septal Defects , 1958, Circulation.